{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:46:16Z","timestamp":1792586776004,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.japh.2019.10.004","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T09:00:55Z","timestamp":1575018055000},"page":"145-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Lofexidine versus clonidine for mitigation of opioid withdrawal symptoms: A systematic review"],"prefix":"10.1016","volume":"60","author":[{"given":"Amanda K.","family":"Kuszmaul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma C.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily K.","family":"Frederick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.japh.2019.10.004_bib5","first-page":"358","article-title":"American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use","volume":"9","author":"Kampman","year":"2015","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.japh.2019.10.004_bib7","series-title":"Lucemyra (lofexidine) [package insert]","year":"2018"},{"key":"10.1016\/j.japh.2019.10.004_bib8","series-title":"Catapres (clonidine hydrochloride) [prescribing information]","year":"2016"},{"issue":"4","key":"10.1016\/j.japh.2019.10.004_bib9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archpsyc.1985.01790270081009","article-title":"Clonidine in outpatient detoxification from methadone maintenance","volume":"42","author":"Kleber","year":"1985","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.japh.2019.10.004_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1360-0443.1990.tb00634.x","article-title":"Efficacy of clonidine, guanfacine and methadone in the rapid detoxification of heroin addicts: a controlled clinical trial","volume":"85","author":"San","year":"1990","journal-title":"Br J Addict"},{"issue":"3","key":"10.1016\/j.japh.2019.10.004_bib11","doi-asserted-by":"crossref","first-page":"336-341","DOI":"10.1038\/clpt.1985.182","article-title":"Efficacy of clonidine and of methadone in the rapid detoxification of patients dependent on heroin","volume":"38","author":"Cam\u00ed","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.japh.2019.10.004_bib12","series-title":"[Boehringer Ingelheim GmbH report number U85-0844]","author":"Senay","year":"1983"},{"key":"10.1016\/j.japh.2019.10.004_bib13","first-page":"CD002024","article-title":"Alpha2-adrenergic agonists for the management of opioid withdrawal","volume":"5","author":"Gowing","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.japh.2019.10.004_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.drugalcdep.2017.02.020","article-title":"A\u00a0phase III, randomized, multi-center, double blind, placebo controlled study of safety and efficacy of lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawal","volume":"176","author":"Gorodetzky","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.japh.2019.10.004_bib17","first-page":"169","article-title":"Safety and efficacy of lofexidine for medically managed opioid withdrawal: a randomized controlled clinical trial","volume":"13","author":"Fishman","year":"2019","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.japh.2019.10.004_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"issue":"1","key":"10.1016\/j.japh.2019.10.004_bib20","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan- a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"1","key":"10.1016\/j.japh.2019.10.004_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0376-8716(96)01316-6","article-title":"Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital","volume":"44","author":"Kahn","year":"1997","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.japh.2019.10.004_bib22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0376-8716(97)00116-6","article-title":"Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal","volume":"48","author":"Lin","year":"1997","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.japh.2019.10.004_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0376-8716(98)00040-4","article-title":"Randomised double-blind comparison of lofexidine and clonidine in the out-patient treatment of opiate withdrawal","volume":"50","author":"Carnwath","year":"1998","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.japh.2019.10.004_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0740-5472(01)00178-7","article-title":"Lofexidine versus clonidine in rapid opiate detoxification","volume":"21","author":"Gerra","year":"2001","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"4","key":"10.1016\/j.japh.2019.10.004_bib25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1360-0443.2003.00372.x","article-title":"Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humans","volume":"98","author":"Walsh","year":"2003","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.japh.2019.10.004_bib26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0306-4603(90)90036-W","article-title":"The development of a short opiate withdrawal scale (SOWS)","volume":"15","author":"Gossop","year":"1990","journal-title":"Addict Behav"},{"issue":"3","key":"10.1016\/j.japh.2019.10.004_bib27","first-page":"CD002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.japh.2019.10.004_bib28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1176\/appi.ajp.2007.06111851","article-title":"A\u00a0meta-analytic review of psychosocial interventions for substance use disorders","volume":"165","author":"Dutra","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.japh.2019.10.004_bib29","first-page":"93","article-title":"A\u00a0systematic review on the use of psychosocial interventions in conjunction with medications for the treatment of opioid addiction","volume":"10","author":"Dugosh","year":"2016","journal-title":"J\u00a0Addict Med"},{"issue":"11","key":"10.1016\/j.japh.2019.10.004_bib30","first-page":"526","article-title":"Cost of pharmacotherapy for opioid use disorders following inpatient detoxification","volume":"24","author":"McCollister","year":"2018","journal-title":"Am J Manag Care"},{"issue":"3","key":"10.1016\/j.japh.2019.10.004_bib31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.addbeh.2005.05.016","article-title":"A\u00a0cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD)","volume":"31","author":"Shanahan","year":"2006","journal-title":"Addict Behav"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319119304534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319119304534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:47:33Z","timestamp":1761544053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319119304534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1544319119304534"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2019.10.004","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lofexidine versus clonidine for mitigation of opioid withdrawal symptoms: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2019.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}